About Us
The Charles B. Wang Community Health Center is a nonprofit and federally qualified health center, established in 1971. We ensure that all members of our community—regardless of ability to pay—are provided with quality, comprehensive and culturally effective primary healthcare.
As a Level 3 Patient-Centered Medical Home, we partner with you to create a health plan that meets your own unique health and social needs. Your health team starts with you and your family, and includes doctors, dentists, nurses, care managers, social workers, health educators, nutritionists and medical assistants. We are located in Chinatown, Manhattan and Flushing, Queens, and are open 7 days a week. We have staff fluent in many languages, including Mandarin, Cantonese, Taishanese, Shanghainese, Fujianese, Vietnamese, and Korean. If you don’t have health insurance, you may qualify for our sliding fee scale to reduce the cost of your care.
We believe that everyone should have the same opportunity to achieve their highest level of health.
Mission
Our mission is to eliminate disparities in health, improve health status, and expand access to the medically underserved with a focus on Asian Americans.
Vision
Our vision is to strive to be a Center for Excellence by being a leader in providing quality, culturally relevant, and affordable health care and education, and advocacy on behalf of the health and social needs of the medically underserved with a focus on Asian Americans.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close